Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years

NCT05312294 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

654

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza
Flu, Human

Interventions

BIOLOGICAL: Flu-M [inactivated split influenza vaccine] without preservative
BIOLOGICAL: Flu-M [inactivated split influenza vaccine] with preservative

Sponsor

St. Petersburg Research Institute of Vaccines and Sera